Search results
Mankind Pharma and Delhivery shares surge up to 4% after block deal
The Economic Times· 2 days agoShares of Mankind Pharma surged 4% to today's high of Rs 2,187.85, while those of Delhivery rose 2%...
Mankind Pharma rallies 5% after 3.7 mn shares change hands via block deal
Business Standard India· 2 days agoMankind Pharma, the domestic pharmaceutical major's stock price surged up to 5.27 per cent at Rs...
Stock market update: Nifty Pharma index falls 0.17% in an upbeat market
The Economic Times· 49 minutes agoThe Nifty Pharma index was trading 0.17 per cent down at 20566.55.
Mankind Pharma block deal: 0.9% stake sold for Rs 771 cr, Capital Group affiliate likely seller
CNBC Awaaz· 2 days agoHema CIPEF owned a 2.22 percent stake in Mankind Pharma, as per the drugmaker's latest shareholding...
Capital Group affiliate Hema CIPEF likely to offload 0.9% stake in Mankind Pharma
CNBC Awaaz· 2 days agoMankind Pharma's block deal will be valued at Rs 762.60 crore, with the issue price set at Rs 2,061...
Mankind Pharma Block Deal: Capital Group affiliate Hema CIPEF likely to sell 0.9% stake - CNBC TV18
CNBC TV18· 3 days agoShares of Mankind Pharma Ltd ended at ₹2,105.45, up by ₹44.80, or 2.17% on the BSE.
Stocks in news: Delta Corp, Paytm, Delhivery, Mankind Pharma, JSW Steel
The Economic Times· 2 days agoDelta Corp's Q1 profit dips 34% to Rs 40.48 crore from Rs 61.43 crore last year. Paytm's One97...
Mankind Pharma Stock Surges: Know Reason Behind Sudden Spike
Times Now· 2 days agoMankind Pharma, a leading pharmaceutical company in India, saw its stock price rise by up to 5.27 per cent to Rs 2,215 per share on the ...
Emcure Pharma lists at 31% premium; should you buy, sell or hold the stock?
Business Standard India· 2 days agoEmcure Pharmaceuticals listing today: According to analysts, Emcure Pharma is quoting at a...
Block deals: Canada Pension Plan sells 0.5% in Nykaa for Rs 256 cr; Hema CIPEF offloads 0.46% in ...
The Economic Times· 2 days agoThrough the stake sale, Canada Pension Plan took home about Rs 256 crore. At the end of March...